Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 7

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 7
---
 on the Company’s Common Equity                                       |     |   35 |
| Management’s Discussion and Analysis of Financial Condition and Results of Operations of Revium Rx |     |   36 |
| Description of Business                                                                            |     |   46 |
| Management                                                                                         |     |  105 |
| Executive Compensation                                                                             |     |  108 |
| Security Ownership of Certain Beneficial Owners & Management                                       |     |  112 |
| Certain Relationships and Related Transactions                                                     |     |  113 |
| Description of Securities                                                                          |     |  114 |
| Shares Eligible for Future Sale                                                                    |     |  116 |
| Legal Matters                                                                                      |     |  116 |
| Experts                                                                                            |     |  116 |
| Where you Can Find More Information                                                                |     |      |
| Financial Statements of Revium Rx.                                                                 |     |  F-1 |

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

This Prospectus is part
of a registration statement on Form S-1 that we filed with the U.S. Securities and Exchange Commission (the “SEC”). You should
read this Prospectus and any documents that we incorporate by reference in this Prospectus before making an investment decision. You
should rely only on the information contained in or incorporated by reference into this Prospectus. We have not authorized anyone to
provide you with information different from that contained in this Prospectus or incorporated by reference herein. No dealer, salesperson
or other person is authorized to give any information or to represent anything not contained in this Prospectus. You must not rely on
any unauthorized information or representation.

This Prospectus is an
offer by the Company to sell only the securities offered hereby but only under circumstances and in jurisdictions where it is lawful
to do so. The distribution of this Prospectus and the issuance of the securities in certain jurisdictions may be restricted by law. Persons
outside the United States who come into possession of this Prospectus must inform themselves about, and observe any restrictions relating
to, the issuance of the securities and the distribution of this prospectus outside the United States. This Prospectus does not constitute,
and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, the securities offered by this Prospectus
by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.

Our business, financial
condition, results of operations and prospects may have